Your browser doesn't support javascript.
loading
Results of two Phase 1, Randomized, Double-blind, Placebo-controlled, Studies (Ascending Single-dose and Multiple-dose Studies) to Determine the Safety, Tolerability, and Pharmacokinetics of Orally Administered LX9211 in Healthy Participants.
Bundrant, LuAnn; Hunt, Thomas L; Banks, Phil; Gopinathan, Suma; Boehm, Kristi A; Kassler-Taub, Kenneth; Tyle, Praveen; Wilson, Alan; Warner, Chris; Wason, Suman.
Afiliación
  • Bundrant L; PPD, Austin, Texas.
  • Hunt TL; PPD, Austin, Texas.
  • Banks P; Lexicon Pharmaceuticals Inc, The Woodlands, Texas.
  • Gopinathan S; Lexicon Pharmaceuticals Inc, The Woodlands, Texas.
  • Boehm KA; Lexicon Pharmaceuticals Inc, The Woodlands, Texas.
  • Kassler-Taub K; Lexicon Pharmaceuticals Inc, The Woodlands, Texas.
  • Tyle P; Lexicon Pharmaceuticals Inc, The Woodlands, Texas.
  • Wilson A; Lexicon Pharmaceuticals Inc, The Woodlands, Texas.
  • Warner C; Lexicon Pharmaceuticals Inc, The Woodlands, Texas.
  • Wason S; Lexicon Pharmaceuticals Inc, The Woodlands, Texas. Electronic address: SWason@lexpharma.com.
Clin Ther ; 43(6): 1029-1050, 2021 06.
Article en En | MEDLINE | ID: mdl-34108079

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Analgésicos / Acetaminofén Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Revista: Clin Ther Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Analgésicos / Acetaminofén Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Revista: Clin Ther Año: 2021 Tipo del documento: Article